Strategy adherence: a specific and rapidly progressive deficit in progressive supranuclear palsy

Strategy adherence: a specific and rapidly progressive deficit in progressive supranuclear palsy

Bibliographic Details
Main Authors:	Brzezicki, MA, Bogdanovic, M, Buchanan, T, FitzGerald, JJ, Antoniades, CA
Format:	Journal article
Language:	English
Published:	Wiley 2021

Similar Items

Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning
by: De Vos, M, et al.
Published: (2020)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
by: Pereira, MF, et al.
Published: (2022)

Longitudinal monitoring of progressive supranuclear palsy using body-worn movement sensors
by: Sotirakis, C, et al.
Published: (2022)

Novel cognitive markers for early diagnosis and monitoring of progressive supranuclear palsy
by: Brzezicki, M, et al.
Published: (2021)

Genetics of Progressive Supranuclear Palsy
by: Sun Young Im, et al.
Published: (2015-09-01)

Clinical Approach to Progressive Supranuclear Palsy
by: Helen Ling
Published: (2016-01-01)

Clinical features of progressive supranuclear palsy
by: Yafei Wen, et al.
Published: (2023-08-01)

Clinical heterogeneity of progressive supranuclear palsy
by: Alexey A. Tappakhov, et al.
Published: (2018-08-01)

Antiparkinsonian medication masks motor signal progression in de novo patients
by: Brzezicki, MA, et al.
Published: (2023)

Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia
by: Shoichiro Ando, et al.
Published: (2020-01-01)

Environmental Risk Factors for Progressive Supranuclear Palsy
by: Hee Kyung Park, et al.
Published: (2021-05-01)

Subjective cognitive complaints in patients with progressive supranuclear palsy
by: Jun Seok Lee, et al.
Published: (2023-12-01)

The Non-Motor Symptom Profile of Progressive Supranuclear Palsy
by: Sudhakar Pushpa Chaithra, et al.
Published: (2020-05-01)

Waiting impulsivity in progressive supranuclear palsy-Richardson’s syndrome
by: Jong Hyeon Ahn, et al.
Published: (2023-09-01)

Alternating flexed-extended posturing in progressive supranuclear palsy
by: Nobuyuki Ishii, et al.
Published: (2019-09-01)

Identification of motor progression in Parkinson's disease using wearable sensors and machine learning
by: Sotirakis, C, et al.
Published: (2023)

Physiotherapy case reports on three people with progressive supranuclear palsy
by: Mariana Mateus, et al.
Published: (2023-12-01)

Increased Subcortical Sodium Levels in Patients with Progressive Supranuclear Palsy
by: Jannik Prasuhn, et al.
Published: (2022-07-01)

Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns
by: Natalia Madetko-Alster, et al.
Published: (2023-10-01)

Imaging Criteria for the Diagnosis of Progressive Supranuclear Palsy: Supportive or Mandatory?
by: Nicoleta Lupascu, et al.
Published: (2023-06-01)

RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations
by: Plamena R. Angelova, et al.
Published: (2021-06-01)

Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
by: Fabio A. Simoes, et al.
Published: (2022-11-01)

Accurate digital quantification of tau pathology in progressive supranuclear palsy
by: Tanrada Pansuwan, et al.
Published: (2023-11-01)

Progressive Supranuclear Palsy in 2022: recent developments and an eye to the future
by: Shane Lyons, et al.
Published: (2022-12-01)

“Penguin” or “Hummingbird” Sign and Midbrain Atrophy in Progressive Supranuclear Palsy
by: Pelin Nar, et al.
Published: (2010-12-01)

“Penguin” or “Hummingbird” Sign and Midbrain Atrophy in Progressive Supranuclear Palsy
by: Pelin Nar, et al.
Published: (2010-12-01)

Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
by: Wataru Uchida, et al.
Published: (2023-08-01)

PROGRESSIVE SUPRANUCLEAR PALSY - PARA-NEOPLASTIC EFFECT OF BRONCHIAL-CARCINOMA - REPLY
by: Pillay, N, et al.
Published: (1985)

Progressive supranuclear palsy: A case report and brief review of the literature
by: Vivek Batheja, MD, et al.
Published: (2024-01-01)

Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy
by: Hiroshi Kataoka, et al.
Published: (2019-09-01)

Levodopa-Induced Facial Dystonia in a Case of Progressive Supranuclear Palsy
by: Eun Joo Chung, et al.
Published: (2012-05-01)

Smaller and Denser Speech Graphs in Nondemented Patients with Progressive Supranuclear Palsy
by: Jinghong Ma, et al.
Published: (2023-01-01)

Sleep architecture in progressive supranuclear palsy: A video-polysomnography study
by: Srikanth Yadav Boini, et al.
Published: (2022-01-01)

Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort - the OxQUIP study
by: Pereira, M, et al.
Published: (2021)

Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
by: Bredemeyer, O, et al.
Published: (2022)

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
by: Ling, H, et al.
Published: (2012)

Sentence completion in progressive supranuclear palsy following transcranial direct current stimulation
by: Johanna Scholtz, et al.
Published: (2023-12-01)

Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women
by: Illana Gozes, et al.
Published: (2023-10-01)

Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy
by: Palaniswamy Ramaswamy, et al.
Published: (2022-05-01)

Clinical Features and Disability Milestones in Multiple System Atrophy and Progressive Supranuclear Palsy
by: Sang-Wook Lee, et al.
Published: (2012-10-01)